Neovasc Inc.

Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ for the treatment of refractory angina and the Tiara™ technology in development for the transcatheter treatment of mitral valve disease. To receive Neovasc updates via email, please register at: http://www.neovasc.com/register.

http://www.neovasc.com

51-200 employees

Growth Trajectory

Shockwave Medical is poised for growth through continued market penetration in existing regions, expansion into new geographic markets, and the development of new applications for its IVL technology. The company's focus on clinical trials and regulatory approvals indicates a commitment to expanding its product offerings and addressing unmet needs in the treatment of calcified cardiovascular disease.

Technical Challenges

Tech Stack

Team Size

Key Risks

Market acceptance and adoption of IVL technology may be slower than anticipated.

Clinical trial results may not consistently demonstrate the superiority of Shockwave IVL over existing treatments.

Regulatory approvals in key markets may be delayed or denied.

Competitors may develop alternative technologies that challenge Shockwave's market position.

Reimbursement rates for IVL procedures may be insufficient to support widespread adoption.

Opportunities

Expand the use of IVL technology into new vascular beds, such as peripheral arteries and coronary arteries.

Develop next-generation IVL devices with enhanced features and capabilities.

Secure partnerships with leading cardiology and vascular centers to drive adoption and research.

Increase awareness and education among physicians and patients about the benefits of IVL.

Explore opportunities to integrate IVL technology with other interventional procedures and devices.

Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats

Access Database

Updated every 5 minutes